Literature DB >> 32134482

Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.

Marisa Marcia Mussi-Pinhata1, Aparecida Yulie Yamamoto1.   

Abstract

Maternal preconceptional cytomegalovirus (CMV) immunity does not protect the fetus from acquiring congenital CMV infection (cCMV). Nonprimary infections due to recurrence of latent infections or reinfection with new virus strains during pregnancy can result in fetal infection. Because the prevalence of cCMV increases with increasing maternal CMV seroprevalence, the vast majority of the cases of cCMV throughout the world follow nonprimary maternal infections and is more common in individuals of lower socioeconomic background. Horizontal exposures to persons shedding virus in bodily secretions (young children, sexual activity, household crowding, low income) probably increase the risk of acquisition of an exogenous nonprimary CMV infection and fetal transmission. In addition, more frequent acquisition of new antibody reactivities in transmitter mothers suggest that maternal reinfection by new viral strains could be a major source of congenital infection in such populations. However, the exact frequency of CMV nonprimary infection in seroimmune women during pregnancy and the rate of intrauterine transmission in these women are yet to be defined. Usually, the birth prevalence of cCMV is high (≥7:1000) in highly seropositive populations. There is increasing evidence that the frequency and severity of the clinical and laboratory abnormalities in infants with congenital CMV infection born to mothers with nonprimary CMV infection are similar to infants born after a primary maternal infection. This is particularly true for sensorineural hearing loss, which contributes to one third of all early-onset hearing loss in seropositive populations. This brief overview will discuss the need for more research to better clarify the natural history of cCMV in highly seropositive populations, which, in almost all populations, remains incompletely defined.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CMV seropositive mothers; congenital infection; cytomegalovirus; highly CMV seropositive populations; natural history

Year:  2020        PMID: 32134482      PMCID: PMC7057789          DOI: 10.1093/infdis/jiz443

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.

Authors:  Aparecida Y Yamamoto; Marisa Marcia Mussi-Pinhata; Myriam de Lima Isaac; Fabiana R Amaral; Cristina G Carvalheiro; Davi C Aragon; Alessandra K da Silva Manfredi; Suresh B Boppana; William J Britt
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus.

Authors:  A J Dahle; K B Fowler; J D Wright; S B Boppana; W J Britt; R F Pass
Journal:  J Am Acad Audiol       Date:  2000-05       Impact factor: 1.664

3.  Mixed infection and strain diversity in congenital cytomegalovirus infection.

Authors:  Shannon A Ross; Zdenek Novak; Sunil Pati; Raj Kumar Patro; Jennifer Blumenthal; Vishwanath R Danthuluri; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; April L Palmer; William J Britt; Karen B Fowler; Suresh B Boppana
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

4.  Valganciclovir for symptomatic congenital cytomegalovirus disease.

Authors:  David W Kimberlin; Penelope M Jester; Pablo J Sánchez; Amina Ahmed; Ravit Arav-Boger; Marian G Michaels; Negar Ashouri; Janet A Englund; Benjamin Estrada; Richard F Jacobs; José R Romero; Sunil K Sood; M Suzanne Whitworth; Mark J Abzug; Mary T Caserta; Sandra Fowler; Jorge Lujan-Zilbermann; Gregory A Storch; Roberta L DeBiasi; Jin-Young Han; April Palmer; Leonard B Weiner; Joseph A Bocchini; Penelope H Dennehy; Adam Finn; Paul D Griffiths; Suzanne Luck; Kathleen Gutierrez; Natasha Halasa; James Homans; Andi L Shane; Michael Sharland; Kari Simonsen; John A Vanchiere; Charles R Woods; Diane L Sabo; Inmaculada Aban; Huichien Kuo; Scott H James; Mark N Prichard; Jill Griffin; Dusty Giles; Edward P Acosta; Richard J Whitley
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

5.  Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Authors:  Adriana S Lopez; Tatiana M Lanzieri; Angelika H Claussen; Sherry S Vinson; Marie R Turcich; Isabella R Iovino; Robert G Voigt; A Chantal Caviness; Jerry A Miller; W Daniel Williamson; Craig M Hales; Stephanie R Bialek; Gail Demmler-Harrison
Journal:  Pediatrics       Date:  2017-11       Impact factor: 7.124

6.  Molecular epidemiology of cytomegalovirus infections in women and their infants.

Authors:  E S Huang; C A Alford; D W Reynolds; S Stagno; R F Pass
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

Review 7.  The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model.

Authors:  Jutte J C de Vries; Erik W van Zwet; Friedo W Dekker; Aloys C M Kroes; Paul H Verkerk; Ann C T M Vossen
Journal:  Rev Med Virol       Date:  2013-04-05       Impact factor: 6.989

8.  Factors associated with primary cytomegalovirus infection during pregnancy.

Authors:  S Stagno; G Cloud; R F Pass; W J Britt; C A Alford
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

9.  Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection.

Authors:  S Stagno; R F Pass; M E Dworsky; R E Henderson; E G Moore; P D Walton; C A Alford
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245

10.  Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India.

Authors:  Lalit Dar; Sunil Kumar Pati; A Raj Kumar Patro; Ashok Kumar Deorari; Sanjay Rai; Shashi Kant; Shobha Broor; Karen B Fowler; William J Britt; Suresh B Boppana
Journal:  Pediatr Infect Dis J       Date:  2008-09       Impact factor: 2.129

View more
  3 in total

1.  Human Cytomegalovirus Seroprevalence Among Blood Donors in the Madinah Region, Saudi Arabia.

Authors:  Waleed Mahallawi; Omar F Khabour; Abdullah Al-Saedi; Ziyad Almuzaini; Nadir Ibrahim
Journal:  Cureus       Date:  2022-02-03

2.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021

3.  Cytomegalovirus infections in infants in Uganda: Newborn-mother pairs, neonates with sepsis, and infants with hydrocephalus.

Authors:  Christine Hehnly; Paddy Ssentongo; Lisa M Bebell; Kathy Burgoine; Joel Bazira; Claudio Fronterre; Elias Kumbakumba; Ronald Mulondo; Edith Mbabazi-Kabachelor; Sarah U Morton; Joseph Ngonzi; Moses Ochora; Peter Olupot-Olupot; John Mugamba; Justin Onen; Drucilla J Roberts; Kathryn Sheldon; Shamim A Sinnar; Jasmine Smith; Peter Ssenyonga; Julius Kiwanuka; Joseph N Paulson; Frederick A Meier; Jessica E Ericson; James R Broach; Steven J Schiff
Journal:  Int J Infect Dis       Date:  2022-02-09       Impact factor: 12.074

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.